“Chennai Declaration”: 5-year plan to tackle the challenge of anti-microbial resistance. Go to Publication You Might Also Like MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network September 3, 2020 Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis. October 23, 2017 Importance of Therapeutic Drug Monitoring of Rifampicin. August 14, 2016 A 24-year-old man with giddiness, hemoptysis, and skin lesions. November 13, 2008 Disseminated tuberculosis with immune thrombocytopenic purpura. January 29, 2012
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network September 3, 2020
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis. October 23, 2017